HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis.

Abstract
The obligately intracellular bacterium Ehrlichia chaffeensis that resides in mononuclear phagocytes is the etiologic agent of human monocytotropic ehrlichiosis (HME). HME is an emerging and often life-threatening, tick-transmitted infectious disease in the United States. Effective primary immune responses against Ehrlichia infection involve generation of Ehrlichia-specific gamma interferon (IFN-γ)-producing CD4(+) T cells and cytotoxic CD8(+) T cells, activation of macrophages by IFN-γ, and production of Ehrlichia-specific antibodies of the Th1 isotype. Currently, there are no vaccines available against HME. We evaluated the ability of 28-kDa outer membrane proteins (P28-OMP-1) of the closely related Ehrlichia muris to stimulate long-term protective memory T and B cell responses and confer protection in mice. The spleens of mice vaccinated with E. muris P28-9, P28-12, P28-19, or a mixture of these three P28 proteins (P28s) using a DNA prime-protein boost regimen and challenged with E. muris had significantly lower bacterial loads than the spleens of mock-vaccinated mice. Mice immunized with P28-9, P28-12, P28-19, or the mixture induced Ehrlichia-specific CD4(+) Th1 cells. Interestingly, mice immunized with P28-14, orthologs of which in E. chaffeensis and E. canis are primarily expressed in tick cells, failed to lower the ehrlichial burden in the spleen. Immunization with the recombinant P28-19 protein alone also significantly decreased the bacterial load in the spleen and liver compared to those of the controls. Our study reports, for the first time, the protective roles of the Ehrlichia P28-9 and P28-12 proteins in addition to confirming previous reports of the protective ability of P28-19. Partial protection induced by immunization with P28-9, P28-12, and P28-19 against Ehrlichia was associated with the generation of Ehrlichia-specific cell-mediated and humoral immune responses.
AuthorsPatricia A Crocquet-Valdes, Nagaraja R Thirumalapura, Nahed Ismail, Xuejie Yu, Tais B Saito, Heather L Stevenson, Colette A Pietzsch, Sunil Thomas, David H Walker
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 18 Issue 12 Pg. 2018-25 (Dec 2011) ISSN: 1556-679X [Electronic] United States
PMID22030371 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Vaccines, DNA
  • Vaccines, Subunit
Topics
  • Animals
  • Bacterial Load
  • Bacterial Outer Membrane Proteins (genetics, immunology)
  • Bacterial Vaccines (administration & dosage, genetics, immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • Ehrlichia (genetics, immunology)
  • Ehrlichiosis (immunology, prevention & control)
  • Humans
  • Immunization (methods)
  • Liver (microbiology)
  • Mice
  • Spleen (microbiology)
  • Th1 Cells (immunology)
  • United States
  • Vaccines, DNA (administration & dosage, genetics, immunology)
  • Vaccines, Subunit (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: